A new in-person science and engineering research fair for middle school students from Westchester, Rockland and Putnam counties will premier on Saturday, April 26 at Edgemont High School. The ...

Fianlimab combined with cemiplimab-rwlc (Regeneron’s Libtayo ... M.D., of Sarah Cannon Research Institute in Nashville, Tennessee, and colleagues, wrote in a poster presentation of the data. The ...

The market research report by IMARC encompasses a comprehensive analysis ... in different phases of developing different therapies are Roche, 3M Pharmaceuticals, Regeneron Pharmaceuticals, Sun ...

According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent ...

Immuneering (IMRX) announced a clinical supply agreement with Regeneron Pharmaceuticals (REGN) for its anti-PD-1 therapy, Libtayo. The supply ...

Regeneron hosted a celebration to recognize the achievements of the 17 students selected as the Westchester 2025 Regeneron Science Talent Search Scholars. Beginning in 1942, the contest […] ...

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

As for revenue, Regeneron reported it at $3.79 billion for the fourth quarter, which was up 10% year over year. The company's full-year haul came in at $14.2 billion, which was an increase of 8%.

Regeneron Pharmaceuticals ... From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. This company targets millennial and Gen Z audiences ...

Biotech giant Regeneron Pharmaceuticals ... Amgen is scheduled to release fourth-quarter results on Feb. 4, 2025. Research Chief Names "Single Best Pick to Double" From thousands of stocks ...

“We purchased Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), a biopharmaceutical company that was built on a foundation in basic scientific research and antibody development. The company has ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals ... global funding for cancer research has grown exponentially over the past two decades. The FDA approved 161 ...